AS Tallinna Vesi (TAL:TVE1T)

Verve Therapeutics Ratios and Metrics

Market cap in millions EUR. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jul 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	213	204	212	251	290	265
Market Cap Growth	2.43%	-3.77%	-15.47%	-13.40%	9.28%	13.25%
Enterprise Value	330	310	291	318	341	310
PE Ratio	15.54	15.36	16.51	29.84	17.92	15.84
PS Ratio	3.26	3.17	3.47	4.60	5.43	5.12
PB Ratio	1.72	1.70	1.81	2.26	2.51	2.36
P/FCF Ratio	-	-	-	-	33.16	38.18
P/OCF Ratio	7.61	7.77	8.65	16.69	12.89	11.71
EV/Sales Ratio	5.05	4.82	4.76	5.83	6.40	6.00
EV/EBITDA Ratio	11.75	11.52	11.70	17.99	15.99	13.49
EV/EBIT Ratio	17.04	16.36	16.76	28.17	22.47	18.31
EV/FCF Ratio	-15.62	-	-	-	39.03	44.73
Debt / Equity Ratio	1.02	1.00	0.85	0.75	0.74	0.80
Debt / EBITDA Ratio	4.48	4.39	3.90	4.57	3.95	3.85
Debt / FCF Ratio	-	-	-	-	9.81	12.88
Quick Ratio	1.01	0.64	1.22	1.15	2.77	3.78
Current Ratio	1.08	0.76	1.30	1.24	2.83	3.85
Asset Turnover	0.22	0.22	0.23	0.21	0.21	0.20
Return on Equity (ROE)	11.25%	11.20%	11.27%	7.43%	14.20%	14.69%
Return on Assets (ROA)	3.98%	3.98%	4.05%	2.77%	3.70%	4.09%
Return on Capital (ROIC)	5.16%	5.19%	5.29%	3.57%	4.71%	5.17%
Return on Capital Employed (ROCE)	6.40%	6.50%	6.60%	4.80%	6.30%	7.00%
Earnings Yield	6.44%	6.51%	6.06%	3.35%	5.58%	6.31%
Earnings Yield	6.44%	6.51%	6.06%	3.35%	5.58%	6.31%
FCF Yield	-9.91%	-8.08%	-2.06%	-2.26%	3.02%	2.62%
Dividend Yield	4.98%	5.44%	5.29%	2.98%	5.33%	6.08%
Payout Ratio	73.45%	75.80%	50.72%	152.69%	79.44%	118.86%
Total Shareholder Return	5.00%	5.44%	5.29%	2.98%	5.33%	6.08%

Updated Feb 7, 2025. Source: S&P Global Market Intelligence. Utility template. Financial Sources.